CVS Health Corporation’s CVS Pharmacy Services business has been gaining momentum on the back of higher specialty pharmacy and pharmacy network claim volumes besides brand inflation.
We expect this strength to get reflected in third-quarter 2019 results, which are scheduled for release on Nov 6, before market open.
Click here to know how the company is likely to perform in the quarter to be reported.
Pharmacy Services Segment in Focus
Consistent with the prior quarters, net new business and the continued adoption of Maintenance Choice programs are once again expected to have driven CVS’ PBM business in the third quarter. Strong claims volume and favourable purchasing economics are once again expected to have boosted the top line. The company’s new guaranteed net cost pricing model is drawing clients and benefit consultants’ attention, which is likely to have led to client uptakes in the third quarter.
CVS Health Corporation Price and EPS Surprise
CVS Health Corporation price-eps-surprise | CVS Health Corporation Quote
Caremark legacy business is also expected to have delivered a strong quarter, banking on the company’s solid execution of its formulary and cost-management tools. In terms of unit cost, the company is successful in driving down the average out-of-pocket costs for plan members over the sixth consecutive year, retaining patients’ adherence and improving their overall health. This trend has most likely continued in the third quarter as well.
Last but not the least, the company earlier noted that post the Aetna acquisition, its Pharmacy Services segment's current-year figures might be affected by two important changes. Firstly, due to the shift of the company’s Individual SilverScript PDP from the PBM segment to its newly-formed Health Care Benefits (HCB) unit. Secondly, the company already integrated the pharmacy operations of Aetna into its PBM. We therefore expect these factors to impact the yet-to-be-reported quarter’s top-line results.
Zacks Ranks and Key Picks
CVS Health currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
DENTSPLY SIRONA XRAY has an Earnings ESP of +5.05% and a Zacks Rank of 3.
AmerisourceBergen Company ABC has an Earnings ESP of +0.55% and is Zacks #3 Ranked.
Cardinal Health, Inc. CAH has an Earnings ESP of +0.69% and is a #3 Ranked stock. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DENTSPLY SIRONA Inc. (XRAY) : Free Stock Analysis Report
CVS Health Corporation (CVS) : Free Stock Analysis Report
AmerisourceBergen Corporation (ABC) : Free Stock Analysis Report
Cardinal Health, Inc. (CAH) : Free Stock Analysis Report
To read this article on Zacks.com click here.